Is science getting closer to identifying ways to reverse hearing loss from damaged hair cells?
This article discusses recent findings from the research team at the Johns Hopkins School of Medicine in Baltimore, Maryland, who investigated cochlear hair cell differentiation in mice during development.
The identification of two proteins, Activin A and follistatin, in this study may lead to innovative treatment options for hearing loss in the future. This article provides an overview of how these proteins contribute to cochlear hair cell development, and the implications this may have for future treatments of sensorineural hearing loss.
Reference
Paddock C. (2019) Protein discovery could lead to new hearing loss treatments. Medical News Today. August 7.
Recent Posts
Academy Advocacy on Capitol Hill for Student Loan Reform and EHDI Support
Last week, Joanne Zurcher, MPP, and Academy member Melissa Heche, AuD, traveled to Capitol Hill to advocate for two important Academy priorities: protecting access to…
A New Era in Hearing Care: FDA Approves OTOF Gene Therapy
In the United States, mutations in the OTOF-gene (otoferlin gene) account for between one percent and eight percent of non-syndromic congenital hearing loss (Ford et…
Academy Board Election Results 2026
We are pleased to announce the newly elected members-at-large and president-elect who will join your Academy Board of Directors. President-Elect The president-elect will serve a…


